Replimune (REPL) Other Non Operating Income (2017 - 2026)
Replimune (REPL) reported Other Non Operating Income of -$77000.0 for Q1 2026, down 111.88% on a YoY basis from $648000.0 in Q1 2025, and up 86.72% sequentially from -$580000.0 in Q4 2025.
Replimune (REPL) Other Non Operating Income (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of Other Non Operating Income data on file, last reported at -$77000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 111.88% year-over-year to -$77000.0; the trailing twelve-month figure through Mar 2026 stood at -$942000.0 (down 373.37% YoY), and the FY2026 full-year result was -$942000.0, down 366.34% from the prior year.
- Other Non Operating Income rose to -$77000.0 in Q1 2026, from -$580000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.0 million in Q3 2024 to a low of -$3.3 million in Q4 2024.
- A 5-year average of -$367882.4 and a median of -$210000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 701.19% in 2022 and surged 814.29% in 2023, its largest moves.
- Tracing REPL's Other Non Operating Income over 5 years: stood at $147000.0 in 2022, then surged by 814.29% to $1.3 million in 2023, then slumped by 344.12% to -$3.3 million in 2024, then surged by 82.32% to -$580000.0 in 2025, then soared by 86.72% to -$77000.0 in 2026.
- Business Quant data shows REPL's Other Non Operating Income at -$77000.0 in Q1 2026, -$580000.0 in Q4 2025, and -$876000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | -580,000.00 |
| Sep 30, 2025 | -876,000.00 |
| Jun 30, 2025 | 591,000.00 |
| Mar 31, 2025 | 648,000.00 |
| Dec 31, 2024 | -3.28 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 406,000.00 |
| Mar 31, 2024 | -536,000.00 |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | -1.15 Mn |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | -2.66 Mn |
| Jun 30, 2022 | -2.02 Mn |
| Mar 31, 2022 | -210,000.00 |
| Dec 31, 2021 | -241,000.00 |
| Sep 30, 2021 | -356,000.00 |
| Jun 30, 2021 | -252,000.00 |